A Novel Antisense lncRNA NT5E Promotes Progression by Modulating the Expression of SYNCRIP and Predicts a Poor Prognosis in Pancreatic Cancer
2024
Correction to a Study on Antisense lncRNA NT5E in Pancreatic Cancer
Editorial
Author Information
Author(s): P. Zhang, M. Cao, Y. Zhang
Conclusion
The correction addresses an error in the placement of a figure in the original publication.
Supporting Evidence
- The correction clarifies an error in the original figure placement.
- The study investigates the role of lncNT5E in pancreatic cancer progression.
Takeaway
There was a mistake in a figure in a study about pancreatic cancer, and it has been corrected.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website